UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (385075) 385075
Newspaper Article (31827) 31827
Newsletter (4219) 4219
Book Chapter (2421) 2421
Web Resource (1760) 1760
Dissertation (774) 774
Magazine Article (264) 264
Publication (217) 217
Book / eBook (137) 137
Trade Publication Article (135) 135
Conference Proceeding (121) 121
Government Document (104) 104
Reference (30) 30
Book Review (24) 24
Streaming Video (15) 15
Poster (7) 7
Paper (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (299063) 299063
life sciences & biomedicine (265090) 265090
humans (198602) 198602
animals (172331) 172331
kinases (139617) 139617
proteins (85797) 85797
mice (79615) 79615
oncology (76589) 76589
phosphorylation (76266) 76266
male (72832) 72832
signal transduction (70578) 70578
cell biology (66444) 66444
female (62179) 62179
biochemistry & molecular biology (60637) 60637
apoptosis (57942) 57942
gene expression (51166) 51166
rats (47511) 47511
research (46656) 46656
cancer (45822) 45822
cell line, tumor (45550) 45550
cells, cultured (40604) 40604
research article (37462) 37462
mutation (34991) 34991
cell cycle (32841) 32841
science & technology - other topics (32779) 32779
multidisciplinary sciences (32117) 32117
signal transduction - drug effects (31496) 31496
cell line (31409) 31409
medicine (31182) 31182
protein kinases (29726) 29726
analysis (29691) 29691
enzyme inhibitors - pharmacology (28961) 28961
rodents (28376) 28376
tumors (28374) 28374
pharmacology & pharmacy (27545) 27545
science (25366) 25366
physiological aspects (25355) 25355
cell proliferation (25317) 25317
genetic aspects (25301) 25301
health aspects (24612) 24612
middle aged (24597) 24597
neurosciences (23841) 23841
apoptosis - drug effects (23607) 23607
protein kinase inhibitors - pharmacology (23477) 23477
biology (23441) 23441
physiology (21811) 21811
neurosciences & neurology (21699) 21699
studies (21311) 21311
cell growth (20799) 20799
adult (20390) 20390
metastasis (19834) 19834
inflammation (19813) 19813
cancer therapies (19494) 19494
immunology (19490) 19490
blotting, western (19364) 19364
aged (19302) 19302
care and treatment (19034) 19034
cell proliferation - drug effects (18824) 18824
enzymes (18493) 18493
biochemistry (18393) 18393
protein-serine-threonine kinases - metabolism (18256) 18256
dose-response relationship, drug (18245) 18245
medicine, research & experimental (18213) 18213
research & experimental medicine (18192) 18192
enzyme activation (17065) 17065
rats, sprague-dawley (17062) 17062
breast cancer (17033) 17033
antineoplastic agents - pharmacology (16846) 16846
genes (16598) 16598
phosphorylation - drug effects (16542) 16542
abridged index medicus (16454) 16454
mice, inbred c57bl (16445) 16445
cytokines (16236) 16236
protein binding (15695) 15695
protein kinase c - metabolism (15535) 15535
medical research (15309) 15309
signal transduction - physiology (15165) 15165
time factors (15132) 15132
immunohistochemistry (15078) 15078
transfection (14926) 14926
chemotherapy (14765) 14765
hematology (14764) 14764
mitogen-activated protein kinases - metabolism (14417) 14417
signaling (14384) 14384
development and progression (14124) 14124
tyrosine (14038) 14038
proto-oncogene proteins c-akt - metabolism (13994) 13994
deoxyribonucleic acid--dna (13986) 13986
protein kinase inhibitors - therapeutic use (13960) 13960
stem cells (13945) 13945
tumor cells, cultured (13546) 13546
metabolism (13477) 13477
disease models, animal (13331) 13331
lung cancer (13207) 13207
chemistry (12974) 12974
transcription factors (12944) 12944
binding sites (12867) 12867
life sciences (12804) 12804
molecular sequence data (12782) 12782
medical prognosis (12262) 12262
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (72) 72
Gerstein Science - Stacks (34) 34
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Chemistry (A D Allen) - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (423154) 423154
Chinese (2623) 2623
Japanese (2573) 2573
French (854) 854
German (800) 800
Russian (551) 551
Portuguese (329) 329
Spanish (238) 238
Korean (194) 194
Polish (130) 130
Czech (82) 82
Norwegian (81) 81
Hungarian (74) 74
Italian (69) 69
Dutch (50) 50
Ukrainian (29) 29
Danish (23) 23
Swedish (18) 18
Turkish (18) 18
Croatian (17) 17
Slovak (11) 11
Finnish (10) 10
Hebrew (6) 6
Bulgarian (4) 4
Serbian (4) 4
Latin (3) 3
Slovenian (3) 3
Persian (2) 2
Romanian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Methods in molecular biology, ISBN 1617793361, Volume 795., xi, 256
Book
2012, Methods in molecular biology, ISBN 9781617794292, Volume 821., xiii, 464
Book
Cancer discovery, ISSN 2159-8290, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or metastatic solid tumors, including patients... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2017, Volume 35, Issue 19, pp. 2193 - 2202
.... We hypothesize the programmed death-ligand 1 (PD-L1) inhibitor, durvalumab, olaparib, or cediranib combinations are tolerable and active in recurrent women's cancers... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Phthalazines - pharmacokinetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Quinazolines - pharmacokinetics | Protein Kinase Inhibitors - adverse effects | Dose-Response Relationship, Drug | Genital Neoplasms, Female - drug therapy | Adult | Female | Quinazolines - administration & dosage | Piperazines - pharmacokinetics | Phthalazines - administration & dosage | Antibodies, Monoclonal - pharmacokinetics | Genital Neoplasms, Female - immunology | B7-H1 Antigen - immunology | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Genital Neoplasms, Female - metabolism | Protein Kinase Inhibitors - administration & dosage | B7-H1 Antigen - antagonists & inhibitors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | B7-H1 Antigen - biosynthesis | Quinazolines - adverse effects | Aged | Genital Neoplasms, Female - pathology | Phthalazines - adverse effects | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | Phase I and Clinical Pharmacology | Combined Modality | Breast Cancer | ORIGINAL REPORTS
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 05/2015, Volume 125, Issue 5, pp. 1780 - 1789
Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases... 
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunotherapy - methods | Apoptosis - drug effects | Humans | Substrate Specificity | Drug Resistance, Neoplasm | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neoplasms - genetics | Protein Processing, Post-Translational - drug effects | Drug Design | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Neoplasm Proteins - genetics | Molecular Targeted Therapy - methods | Neoplasms - enzymology | Gene Fusion | Enzyme Activation - drug effects | Neoplasms - drug therapy | Drug Synergism | Point Mutation | Gene Amplification | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Oncogene Proteins, Fusion - antagonists & inhibitors | Signal Transduction - physiology | Protein Kinase Inhibitors - pharmacology | Apoptosis - physiology | Enzyme inhibitors | Physiological aspects | Research | Drug therapy | Phosphotransferases | Health aspects | Cancer | Proteins | Phosphorylation | Gene amplification | Biology | Regulation | Genomes | Mutation | Metastasis | Kinases | Phosphatase | Tumors | Index Medicus | Abridged Index Medicus | Review
Journal Article
Journal Article